Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer
- PMID: 39827880
- PMCID: PMC11866478
- DOI: 10.1016/j.xcrm.2025.101944
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer
Figures




Erratum for
-
Lurbinectedin sensitizes PD-L1 blockade therapy by activating STING-IFN signaling in small-cell lung cancer.Cell Rep Med. 2024 Dec 17;5(12):101852. doi: 10.1016/j.xcrm.2024.101852. Epub 2024 Dec 9. Cell Rep Med. 2024. PMID: 39657664 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials